Cannabis and Hemp Industry Investment News
What are you searching for? viewInnoCan Pharma The firm said it will use the cash to fund research and product development costs, sales, marketing and...
Proceeds from the offering will also be used to fund the group's application process to list on a senior US exchange The Canadian company raised a tot...
The money will be used to fund research and product development costs, sales, marketing and operating expenses InnoCan Pharma is a specialty pharma gr...
Looking to produce high-grade cannabis and hemp ingredientsTargeting pharmaceutical, therapeutic. nutraceutical and cosmetic industries.Creating indus...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Ltd () (OTCQB:AAGF) said it had closed its previously an...
The company has also signed an outline letter of intent with one counterparty for the offtake of the eventual supply of finished pharmaceutical and me...
A portion of the funds will be used for the group's human pilot study on DehydraTECH's ability to boost the oral bioavailability of antiviral drugs Le...
Professor Offen works at the Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience at Tel...
InnoCan Pharma planning to develop new line of CBD products and formulations with Tamar Technologies
Tamar Technologies is licensing InnoCan’s formulations and expertise as part of a cooperation agreement that the two companies signed in April 2019 Ta...
The company has several catalysts signifying progression to watch for. This progression is important as it serves as a stepping-stone to its goal - ne...
The group has received a Notice of Allowance from the US Patent and Trademark Office for a new patent to protect the use of its technology in mix-and-...
What are you searching for? viewInnoCan Pharma Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver to bring ne...
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE: LXX-OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive V...
The firm's patented drug delivery technology changes the way active pharmaceutical ingredients enter a patient's bloodstream Acute respiratory distres...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Ltd (CSE:SWIS) () is close to launching its data protect...
The University of Sydney has validated Medlab’s NanoCelle™ Chloroquine (CQ) nanoparticle characteristics. Medlab’s core focus remains across the chron...
CBD-loaded Exosomes hold the potential to provide anti-inflammatory properties and help infected lung cells to recover The lungs are the organ most af...
An announcement is pending in relation to an extension of Medlab’s NanoCelle™ platform to anti-malaria drugs. A trading halt has been granted until Ap...
The company is developing therapies for pain management, depression and obesity as well as earning revenue from the sale of nutritional products in Au...
's () Dr Sean Hall caught up with Proactive's Andrew Scott after signing a Heads of Agreement (HoA) with Randall Communications Pty Ltd - trading as F...
